Groove Biopharma

Groove Biopharma Focuses on Generating Novel microRNA (miRNA) Therapies with Improved Properties, Including Higher Potency and Enhanced Pharmacodynamic Activity. Endogenous microRNAs (miRNAs) Are Involved in Extensive Regulatory Networks of Many Target Genes and Pathways. Groove Biopharma’s Core Technology Addresses New Avenues in Nucleotide Therapeutics Discovery by Modulating Cellular miRNAs. Using Exclusive Technology, Groove Biopharma Is Developing a Range of Drug Candidates with the Potential to Become Best-in-Class Therapies. By Incorporating Proprietary Structural Modifications into miRNA Therapies, Groove Biopharma’s Technology Platform Offers Significant Potential for Treating a Wide Range of Diseases, Including Cancer, Fibrosis, and Infectious Diseases.